The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.
Open accessAbstract
To determine if reactive oxygen metabolites have a pathogenic role in Helicobacter pylori (H pylori) related gastroduodenal disease, this study measured their production in antral mucosal biopsy specimens. Two related chemiluminescence techniques were used comparing H pylori positive (n = 105) and negative patients (n = 64) with a similar spectrum of macroscopic disease. After chemiluminescence assays, biopsy specimens were graded histologically. Increased luminol dependent chemiluminescence (detecting reactive oxygen metabolites through peroxidase catalysed reactions) was found in H pylori positive patients (median photon emission = 6.4 x 10(3)/min/mg wet weight (95% confidence intervals 3.6 to 9.9)) but not H pylori negative cases (-0.9 (-1.3 to -0.6)) (p = 0.0001). Similar results were found using lucigenin (which reacts directly with oxygen metabolites, particularly superoxide): (H pylori positive 0.9 (0.1 to 3.2); H pylori negative -1.2 (-3.4 to -0.6)) (p = 0.0003). Chemiluminescence was greater in H pylori positive compared with negative tissue when samples were grouped by equivalent macroscopic or microscopic damage. This difference was in part accounted for by a greater neutrophil infiltration in the H pylori positive mucosa, but when biopsy specimens with equivalent neutrophil infiltration could be compared directly, positive specimens gave greater chemiluminescence than negative. Smoking, drugs, and alcohol consumption had no independent effect. It is concluded that excess mucosal reactive oxygen metabolite production is associated with H pylori gastric antral infection and may be an important pathogenic mechanism. There is no evidence for reactive oxygen metabolite participation in the pathogenesis of gastric mucosal injury in cases unrelated to H pylori infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
The estimation of the bactericidal power of the blood
Miles, A. A., Misra, S. S., & Irwin, J. O. (1938) · Epidemiology and Infection · doi:10.1017/s002217240001158x · Cited by 3,583
Free radicals, antioxidants, and human disease: where are we now?
Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · PubMed · Cited by 2,610
Helicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
Oxidants from phagocytes: agents of defense and destruction
Babior, B. (1984) · Blood · doi:10.1182/blood.v64.5.959.959 · Cited by 807
Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis
Weitzman, S., & Gordon, L. (1990) · Blood · doi:10.1182/blood.v76.4.655.655 · Cited by 764
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.
Morris, A., & Nicholson, G. I. (1987) · PubMed · Cited by 741
Helicobacter pylori and the Pathogenesis of Gastroduodenal Inflammation
Blaser, M. J. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.4.626 · Cited by 671
Neutrophil-mediated mucosal injury: Role of reactive oxygen metabolites
Grisham, M. B., & Granger, D. N. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01538126 · Cited by 433
An overview of the relationship between oxidative stress and chemical carcinogenesis
Trush, M. A., & Kensler, T. W. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90077-g · Cited by 372
Cited by
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
“This pathogen also enhances gastric antral ROS production which is correlated with bacterial load (73).”
BackgroundInflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Hydroxyl Radical is the Major Causative Factor in Stress-Induced Gastric Ulceration
Das, D., Bandyopadhyay, D., Bhattacharjee, M., & Banerjee, R. K. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00547-3 · Cited by 323
Ciobica, A., Balmus, I., Trifan, A., & Stanciu, C. (2016) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.173753 · Cited by 292
Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., & Banerjee, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210328200 · Cited by 291
ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello, G., & Knaus, U. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13428 · Cited by 278
Redox signaling in the gastrointestinal tract
Pérez, S., Taléns-Visconti, R., Rius-Pérez, S., Finamor, I., & Sastre, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.048 · Cited by 273
Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics
Carmody, R. N., & Turnbaugh, P. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72335 · Cited by 268
“H. pylori may affect l-DOPA bioavailability by disrupting absorption at the duodenal mucosa (34), by producing ROS that inactivate the drug (35, 36), and via direct metabolism of l-DOPA (37).”
Oxidative DNA damage accumulation in gastric carcinogenesis
Farinati, F., Cardin, R., Degan, P., Rugge, M., Di Mario, F., Bonvicini, P., & Naccarato, R. (1998) · Gut · doi:10.1136/gut.42.3.351 · Cited by 266
Cellular and molecular aspects of gastric cancer
Smith, M. G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.2979 · Cited by 252
Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA
Chaturvedi, R., Asim, M., Romero–Gallo, J., Barry, D. P., Hoge, S., de Sablet, T., Delgado, A. G., Wroblewski, L. E., Piazuelo, M. B., Yan, F., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.045 · Cited by 208
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease
Lee, W. Y., Yoon, W. T., Shin, H. Y., Jeon, S. H., & Rhee, P. (2008) · Movement Disorders · doi:10.1002/mds.22190 · Cited by 110
Rocha, B. S., Gago, B., Barbosa, R. M., Lundberg, J. O., Radi, R., & Laranjinha, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.011 · Cited by 74
Liu, H., Su, W., Li, S., Du, W., Ma, X., Jin, Y., Li, K., & Chen, H. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.07.003 · Cited by 43
Metadata
- Authors
- Davies, G. R., Simmonds, N. J., Stevens, T. R., Sheaff, M. T., Banatvala, N., Laurenson, I. F., Blake, D. R., & Rampton, D. S.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1994-02
- Volume
- 35
- Issue
- 2
- Pages
- 179-185
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2153419053
- Cited by
- 413
- References
- 19
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.